The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer

•We firmly establish that two anti-HER2 agents with chemotherapy is most effective.•The updated analysis improved data by reducing confidence/credibility intervals.•New pzmb related trials are most required to determine the best regimen. We previously described a systematic assessment of the neoadju...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer treatment reviews 2018-01, Vol.62, p.9-17
Hauptverfasser:	Nakashoji, Ayako, Hayashida, Tetsu, Yokoe, Takamichi, Maeda, Hinako, Toyota, Tomoka, Kikuchi, Masayuki, Watanuki, Rurina, Nagayama, Aiko, Seki, Tomoko, Takahashi, Maiko, Abe, Takayuki, Kitagawa, Yuko
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Dual-HER2 blockade HER2 Human epidermal growth factor receptor-2 Neoadjuvant Network meta-analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!